查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2088968

血液分離設備市場：2026-2032年全球市場預測（按產品類型、技術類型、患者類型、應用、最終用戶和分銷管道分類）

Apheresis Equipment Market by Product Type, Technology Type, Patient Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血液分離設備市場將成長至 64.5 億美元，複合年成長率為 9.33%。

主要市場統計數據
基準年 2025 34.5億美元
預計年份：2026年 37.8億美元
預測年份 2032 64.5億美元
複合年成長率 (%) 9.33%

血液分離設備市場簡介

血液分離裝置在現代輸血醫學、治療性血液分離、幹細胞採集和血漿衍生療法中發揮核心作用。這些系統將全血分離成血漿、血小板、紅血球、白血球或造血幹細胞等成分，以便採集或移除所需的成分，同時將剩餘成分輸回捐贈者或患者體內。

血液分離領域的變革性變化

在血液分離設備領域，操作流程正從人工操作、勞動密集轉向自動化、軟體控制的系統，旨在提高採樣效率、操作一致性和病患安全性。現代平台越來越注重密封或功能性密封的流體通路、整合抗凝血劑控制、自動介面檢測、可配置的方案以及即時程式監控。

人工智慧（AI）的累積影響

人工智慧 (AI) 對血液分離設備的影響並非主要體現在自動取代臨床任務，而是體現在決策支援方面。 AI 驅動的分析功能可輔助安排捐血者和患者的捐血時間、最佳化手術參數、識別不利事件風險、進行庫存規劃、檢測品質趨勢，以及在血液中心和醫院等高使用率環境中進行預測性維護。

對關鍵區域的洞察

由於醫療保健投資增加、患者群體龐大、癌症治療需求不斷成長以及對血漿衍生藥品的需求日益旺盛，亞太地區市場正在擴張。中國、印度、日本、韓國和澳洲是重要的市場中心，其中日本和澳洲擁有成熟的輸血體系，而中國和印度則正在加強其在醫院、血液服務機構和專科中心等方面的體系建設。

關鍵的群體特定見解

東協地區的需求正受到醫院現代化、血液服務改善、醫療旅遊以及新加坡、泰國、馬來西亞、印尼和越南等國私人醫療網路擴張的影響。海灣合作理事會（GCC）國家正在投資建設專科醫院、癌症治療服務、器官移植項目，並致力於實現國家血液自給自足的目標，這催生了對可靠的治療性血液分離系統和捐血血液採集系統的需求。

主要國家的概況

美國在血漿採集規模、治療性血液分離術的引入以及先進的細胞治療基礎設施方面處於主導地位。加拿大則受惠於完善的血液供應系統、健全的醫院醫療保健體系和成熟的臨床管治。墨西哥和巴西正透過公共和私人醫療保健投資擴大醫療服務覆蓋範圍，其中巴西作為拉丁美洲的醫療中心，在三級醫療、輸血服務和專科醫療方面發揮主導作用。

為行業領導者提供的實用建議

產業領導者應優先考慮能夠降低操作人員差異、提高採血效率、增強患者和捐血者安全，並與血庫資訊系統、醫院電子健康記錄、實驗室系統和細胞治療生產流程無縫整合的平台。投資於封閉式系統設計、耗材可靠性、網路安全、遠距離診斷和服務應對力，可增強競爭優勢。

調查方法

本研究方法結合了來自監管機構、公共衛生機構、臨床指南、科學文獻、醫療基礎設施數據以及公開的行業資料的二手研究數據。資訊來源通常包括美國食品藥物管理局（FDA）的醫療設備資訊、歐洲法規結構、世界衛生組織（WHO）的血液安全資料、輸血醫學指南、臨床實踐建議以及同行評審文章。

結論

血液成分分離設備正從專門的輸血基礎設施轉型為精準醫療、血漿供應、治療性介入和先進療法生產的策略平台。這一成長是由臨床需求、技術自動化、數位化可追溯性以及對安全、標準化血液成分採集和處理流程日益成長的需求所驅動的。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 血液分離設備市場：依產品類型分類

  • 拋棄式血漿分離套裝
    • 採血管套裝
    • 篩選
    • 針頭和導管
  • 血液分離設備
    • 自動血液分離裝置
    • 半自動血液分離裝置

第8章 血液分離設備市場：依技術類型分類

  • 離心分離技術
  • 薄膜過濾技術
    • 中空纖維過濾
    • 選擇性血漿過濾
  • 吸附技術
  • 光療技術

第9章 血液分離設備市場：依病患類型分類

  • 成人
  • 兒童

第10章：血液分離設備市場：依應用領域分類

  • 血液樣本
    • 血漿採集
    • 血小板採集
    • 紅血球採集
    • 幹細胞採集
  • 治療用途
    • 神經病變
      • Guillain-Barré二氏症候群
      • 重症肌無力
      • 多發性硬化症
    • 血液疾病
      • 白血病
      • 鐮狀細胞貧血症
      • 血小板減少性疾病
    • 腎臟疾病
      • 腎衰竭
      • 腎絲球腎炎
    • 自體免疫疾病

第11章 血液分離設備市場：依最終用戶分類

  • 血庫
  • 專科診所
  • 醫院
    • 公立醫院
    • 私立醫院
  • 研究機構

第12章 血液分離設備市場：依通路分類

  • 線上
  • 離線

第13章 血液分離設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 血液分離設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 血液分離設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Aferetica srl
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun SE
  • Baxter International Inc.
  • Beijing ZKSK Technology Co., Ltd.
  • Bioelettronica Srl
  • Cerus Corporation
  • Cytosorbents Corporation
  • Fresenius SE & Co. KGaA
  • Guangzhou Daji Medical Science and Technology Co., Ltd.
  • Haemonetics Corporation
  • Haier Biomedical
  • Infomed SA
  • Jafron Biomedical Co., Ltd.
  • Kaneka Corporation
  • Kawasumi Laboratories, Inc.
  • Macopharma SA
  • Medica SpA
  • Miltenyi Biotec BV & Co. KG
  • Nikkiso Co., Ltd.
  • PuriBlood Medical Co., Ltd.
  • Terumo BCT, Inc.
  • Therakos, Inc.
Product Code: MRR-ED54C46E8736

The Apheresis Equipment Market is projected to grow by USD 6.45 billion at a CAGR of 9.33% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.45 billion
Estimated Year [2026] USD 3.78 billion
Forecast Year [2032] USD 6.45 billion
CAGR (%) 9.33%

Apheresis Equipment Market Introduction

Apheresis equipment is central to modern transfusion medicine, therapeutic apheresis, stem cell collection, and plasma-derived therapies. These systems separate whole blood into components such as plasma, platelets, red cells, leukocytes, or hematopoietic stem cells, enabling targeted collection or removal while returning remaining components to the donor or patient.

The market is supported by well-established clinical use cases, including plateletpheresis, plasmapheresis, leukapheresis, extracorporeal photopheresis support workflows, and therapeutic plasma exchange. Demand is reinforced by aging populations, cancer care expansion, autoimmune and hematologic disease management, trauma preparedness, and continued reliance on plasma fractionation for immunoglobulins, albumin, and coagulation factors.

Transformative Shifts in the Apheresis Landscape

The apheresis equipment landscape is shifting from manual, labor-intensive workflows toward automated, software-guided systems designed to improve collection efficiency, operator consistency, and patient safety. Modern platforms increasingly emphasize closed or functionally closed fluid pathways, integrated anticoagulant control, automated interface detection, configurable protocols, and real-time procedure monitoring.

A second transformation is the convergence of apheresis with cell and gene therapy supply chains. Leukapheresis and mononuclear cell collection are critical upstream steps for CAR-T and other advanced therapies, making collection quality, chain-of-identity controls, chain-of-custody documentation, and digital traceability strategic differentiators for hospitals, blood centers, and therapy developers.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence apheresis equipment through decision support rather than autonomous clinical replacement. AI-enabled analytics can support donor and patient scheduling, procedure parameter optimization, adverse event risk flagging, inventory planning, quality trend detection, and predictive maintenance for high-utilization blood center and hospital environments.

The cumulative impact depends on governance. AI applications connected to apheresis workflows must align with medical device quality systems, cybersecurity expectations, clinical validation, data privacy laws such as HIPAA and GDPR, and internationally recognized risk management practices such as ISO 14971. The strongest near-term value is expected in workflow efficiency, quality assurance, utilization management, and equipment uptime.

Key Regional Insights

Asia-Pacific is expanding through rising healthcare investment, large patient populations, increasing oncology care, and growing demand for plasma-derived medicinal products. China, India, Japan, South Korea, and Australia are important anchors, with Japan and Australia supported by mature transfusion systems and China and India advancing capacity across hospitals, blood services, and specialty centers.

North America remains a high-adoption region because of established blood collection infrastructure, FDA-regulated device pathways, strong therapeutic apheresis use, active cellular therapy programs, and extensive plasma collection activity. Latin America shows selective expansion led by Brazil and Mexico, where private hospital networks, public health investment, and tertiary care development support demand for donor and therapeutic apheresis. Europe benefits from structured hemovigilance, EU medical device regulation, mature transfusion networks, and advanced hospital systems, while the Middle East is investing in tertiary care capacity, oncology services, and national health infrastructure, particularly in GCC countries. Africa's opportunity is tied to blood safety modernization, donor infrastructure, infectious disease screening capacity, and improved access to specialty treatment in major urban medical centers.

Key Group Insights

ASEAN demand is shaped by hospital modernization, improving blood services, medical tourism, and expanding private healthcare networks in countries such as Singapore, Thailand, Malaysia, Indonesia, and Vietnam. The GCC is investing in specialty hospitals, oncology services, transplant programs, and national self-sufficiency goals, creating demand for reliable therapeutic apheresis and donor collection systems.

The European Union is defined by stringent quality, safety, and regulatory requirements, including medical device conformity, blood establishment standards, hemovigilance, and cross-border healthcare quality frameworks. BRICS countries represent scale-driven opportunity, especially where plasma demand, oncology care, and cell therapy programs are expanding alongside broader healthcare infrastructure. G7 markets lead in clinical adoption, reimbursement maturity, evidence-based protocols, and advanced therapy integration, while NATO countries emphasize resilient blood supply chains, emergency preparedness, interoperable healthcare logistics, and continuity of critical medical services.

Key Country Insights

The United States leads in plasma collection scale, therapeutic apheresis adoption, and advanced cellular therapy infrastructure, while Canada benefits from organized blood systems, strong hospital-based care, and established clinical governance. Mexico and Brazil are expanding access through public and private healthcare investment, with Brazil serving as a key Latin American healthcare hub for tertiary care, transfusion services, and specialty medicine.

The United Kingdom, Germany, France, Italy, and Spain maintain advanced transfusion and hospital networks supported by clinical standards, hemovigilance practices, and specialist treatment pathways, while Germany is especially notable for high medical technology adoption and robust hospital infrastructure. Russia has a broad hospital base but faces procurement, access, and supply chain constraints. China and India offer large-volume demand potential driven by population scale, oncology expansion, blood service development, and healthcare investment; Japan and South Korea provide technologically mature markets supported by high clinical standards and advanced hospital systems; and Australia combines strong transfusion governance, high clinical quality expectations, and regional reference capabilities across the Asia-Pacific healthcare ecosystem.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize platforms that reduce operator variability, improve collection yield, enhance patient and donor safety, and integrate seamlessly with blood bank information systems, hospital electronic records, laboratory systems, and cell therapy manufacturing workflows. Investments in closed-system design, consumable reliability, cybersecurity, remote diagnostics, and service responsiveness can strengthen competitive positioning.

Manufacturers and providers should also build evidence packages around procedure efficiency, adverse event reduction, product quality, staff workflow, training efficiency, and total cost of ownership. Partnerships with blood centers, oncology networks, transplant programs, and cell therapy developers can accelerate adoption, while regulatory-ready AI governance and validated digital traceability can create durable differentiation.

Research Methodology

The research approach combines secondary research from regulatory authorities, public health agencies, clinical guidelines, scientific literature, healthcare infrastructure data, and publicly available industry documentation. Sources typically include FDA device information, European regulatory frameworks, WHO blood safety resources, transfusion medicine guidance, clinical practice recommendations, and peer-reviewed publications.

Market interpretation is strengthened through triangulation across device adoption patterns, procedure volumes where publicly available, disease burden indicators, blood and plasma collection trends, hospital capacity, reimbursement context, regulatory requirements, and procurement behavior. Insights are validated by comparing regional dynamics, clinical use cases, technology readiness, and healthcare system maturity across established and emerging markets.

Conclusion

Apheresis equipment is moving from specialized transfusion infrastructure toward a strategic platform for precision medicine, plasma supply, therapeutic intervention, and advanced therapy manufacturing. Growth drivers are supported by clinical necessity, technology automation, digital traceability, and rising demand for safe, standardized blood component collection and therapeutic procedures.

The strongest market participants will combine clinical reliability, digital interoperability, regulatory discipline, service excellence, and evidence-based value demonstration. As AI, cell therapy, plasma-derived medicine demand, and regional healthcare investment reshape adoption priorities, apheresis equipment providers that deliver measurable workflow, safety, and quality improvements will be best positioned for long-term growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Apheresis Equipment Market, by Product Type

  • 7.1. Disposable Apheresis Kits
    • 7.1.1. Blood Tubing Sets
    • 7.1.2. Filters
    • 7.1.3. Needles & Catheters
  • 7.2. Apheresis Devices
    • 7.2.1. Automated Apheresis Machines
    • 7.2.2. Semi-Automated Apheresis Machines

8. Apheresis Equipment Market, by Technology Type

  • 8.1. Centrifugation Technology
  • 8.2. Membrane Filtration Technology
    • 8.2.1. Hollow Fiber Filtration
    • 8.2.2. Selective Plasma Filtration
  • 8.3. Adsorption Technology
  • 8.4. Photopheresis Technology

9. Apheresis Equipment Market, by Patient Type

  • 9.1. Adult
  • 9.2. Pediatric

10. Apheresis Equipment Market, by Application

  • 10.1. Blood Collection
    • 10.1.1. Plasma Collection
    • 10.1.2. Platelet Collection
    • 10.1.3. RBC Collection
    • 10.1.4. Stem Cell Collection
  • 10.2. Therapeutic
    • 10.2.1. Neurological Disorders
      • 10.2.1.1. Guillain-Barre Syndrome
      • 10.2.1.2. Myasthenia Gravis
      • 10.2.1.3. Multiple Sclerosis
    • 10.2.2. Hematological Disorders
      • 10.2.2.1. Leukemia
      • 10.2.2.2. Sickle Cell Disease
      • 10.2.2.3. Thrombocytopenia
    • 10.2.3. Renal Diseases
      • 10.2.3.1. Kidney Failure
      • 10.2.3.2. Glomerulonephritis
    • 10.2.4. Autoimmune Diseases

11. Apheresis Equipment Market, by End User

  • 11.1. Blood Banks
  • 11.2. Specialty Clinics
  • 11.3. Hospitals
    • 11.3.1. Public Hospitals
    • 11.3.2. Private Hospitals
  • 11.4. Research Institutes

12. Apheresis Equipment Market, by Distribution Channel

  • 12.1. Online
  • 12.2. Offline

13. Apheresis Equipment Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Apheresis Equipment Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Apheresis Equipment Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Aferetica srl
  • 17.2. Asahi Kasei Medical Co., Ltd.
  • 17.3. B. Braun SE
  • 17.4. Baxter International Inc.
  • 17.5. Beijing ZKSK Technology Co., Ltd.
  • 17.6. Bioelettronica S.r.l.
  • 17.7. Cerus Corporation
  • 17.8. Cytosorbents Corporation
  • 17.9. Fresenius SE & Co. KGaA
  • 17.10. Guangzhou Daji Medical Science and Technology Co., Ltd.
  • 17.11. Haemonetics Corporation
  • 17.12. Haier Biomedical
  • 17.13. Infomed SA
  • 17.14. Jafron Biomedical Co., Ltd.
  • 17.15. Kaneka Corporation
  • 17.16. Kawasumi Laboratories, Inc.
  • 17.17. Macopharma SA
  • 17.18. Medica S.p.A.
  • 17.19. Miltenyi Biotec B.V. & Co. KG
  • 17.20. Nikkiso Co., Ltd.
  • 17.21. PuriBlood Medical Co., Ltd.
  • 17.22. Terumo BCT, Inc.
  • 17.23. Therakos, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL APHERESIS EQUIPMENT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL APHERESIS EQUIPMENT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL APHERESIS EQUIPMENT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL APHERESIS EQUIPMENT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL APHERESIS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL APHERESIS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DISPOSABLE APHERESIS KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DISPOSABLE APHERESIS KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DISPOSABLE APHERESIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD TUBING SETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD TUBING SETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD TUBING SETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FILTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FILTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FILTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEEDLES & CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEEDLES & CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEEDLES & CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL APHERESIS DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL APHERESIS DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL APHERESIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATED APHERESIS MACHINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATED APHERESIS MACHINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATED APHERESIS MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SEMI-AUTOMATED APHERESIS MACHINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SEMI-AUTOMATED APHERESIS MACHINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SEMI-AUTOMATED APHERESIS MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CENTRIFUGATION TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CENTRIFUGATION TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CENTRIFUGATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEMBRANE FILTRATION TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEMBRANE FILTRATION TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEMBRANE FILTRATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOLLOW FIBER FILTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOLLOW FIBER FILTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOLLOW FIBER FILTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SELECTIVE PLASMA FILTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SELECTIVE PLASMA FILTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SELECTIVE PLASMA FILTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ADSORPTION TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ADSORPTION TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ADSORPTION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHOTOPHERESIS TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHOTOPHERESIS TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHOTOPHERESIS TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PLASMA COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PLASMA COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PLASMA COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PLATELET COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PLATELET COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PLATELET COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RBC COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RBC COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RBC COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STEM CELL COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STEM CELL COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STEM CELL COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GUILLAIN-BARRE SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GUILLAIN-BARRE SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GUILLAIN-BARRE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MYASTHENIA GRAVIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MYASTHENIA GRAVIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MYASTHENIA GRAVIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEMATOLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HEMATOLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEMATOLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LEUKEMIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL LEUKEMIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL LEUKEMIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SICKLE CELL DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SICKLE CELL DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SICKLE CELL DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL THROMBOCYTOPENIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL THROMBOCYTOPENIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL THROMBOCYTOPENIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RENAL DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL RENAL DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL RENAL DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL KIDNEY FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL KIDNEY FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL KIDNEY FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GLOMERULONEPHRITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GLOMERULONEPHRITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GLOMERULONEPHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD BANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD BANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. GCC APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. GCC APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 248. GCC APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. GCC APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. GCC APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. GCC APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. GCC APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. GCC APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 254. GCC APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 255. GCC APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 256. GCC APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 257. GCC APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 258. GCC APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. GCC APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. G7 APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. G7 APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. G7 APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 296. G7 APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 297. G7 APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. G7 APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 299. G7 APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. G7 APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. G7 APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 302. G7 APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 303. G7 APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 304. G7 APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 305. G7 APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 306. G7 APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. G7 APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 308. G7 APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 309. NATO APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. NATO APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. NATO APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 312. NATO APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 313. NATO APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. NATO APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 315. NATO APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. NATO APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 317. NATO APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 318. NATO APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 319. NATO APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 320. NATO APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 321. NATO APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 322. NATO APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 323. NATO APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 324. NATO APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 325. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 342. CANADA APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 343. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 344. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2018-2032 (USD MILLION)
  • TABLE 345. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 346. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 348. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 349. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 350. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 351. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 352. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 353. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 354. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 355. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 356. CANADA APHERESI